Bionano Genomics (BNGO) Operating Leases (2021 - 2026)

Bionano Genomics (BNGO) posted Operating Leases of $2.5 million for Q1 2026, up 0.72% sequentially from $2.5 million in Q4 2025.

Bionano Genomics (BNGO) Operating Leases (2021 - 2026) Analysis & Trends

Bionano Genomics has reported Operating Leases for 6 years, with the latest figure at $2.5 million in Q1 2026.

Quarterly Operating Leases changed N/A year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (changed N/A YoY) and the FY2025 annual result came in at $2.5 million, up 1616.55% from the prior year.
Operating Leases advanced to $2.5 million in Q1 2026 per BNGO's latest filing, from $2.5 million in the prior quarter.
Over five years, Operating Leases peaked at $7.3 million in Q1 2023 and troughed at $145000.0 in Q4 2024.
A 5-year average of $4.1 million and a median of $4.2 million in 2024 frame the typical range for Operating Leases.
The sharpest annual moves came in 2024 and 2025: Operating Leases sank 95.96% in 2024, then jumped 1616.55% in 2025.
Over 5 years, Operating Leases stood at $5.5 million in 2022, then tumbled by 34.77% to $3.6 million in 2023, then tumbled by 95.96% to $145000.0 in 2024, then surged by 1616.55% to $2.5 million in 2025, then grew by 0.72% to $2.5 million in 2026.
According to Business Quant data, Operating Leases over the past three periods registered $2.5 million, $2.5 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	134.86 Bn	129.64 Bn	1.96 Bn
2	Becton Dickinson	52.52 Bn	51.66 Bn	2.32 Bn
3	Alcon	35.73 Bn	34.38 Bn	1.68 Bn
4	Resmed	34.00 Bn	32.53 Bn	861.22 Mn
5	Medline	29.17 Bn	26.49 Bn	2.22 Bn
6	West Pharmaceutical Services	24.80 Bn	24.37 Bn	329.20 Mn
7	Solventum	15.29 Bn	14.89 Bn	1.29 Bn
8	Cooper Companies	14.84 Bn	14.70 Bn	735.40 Mn
9	Baxter International	13.64 Bn	11.49 Bn	1.03 Bn
10	Bionano Genomics	14.43 Mn	4.50 Mn	4.31 Mn

Download Data